Timing of carbon nanoparticles injection for thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether the timing of a carbon nanoparticle injection during thyroid cancer surgery improves outcomes. It may help patients who need their whole thyroid removed and have cancer in both lobes or spread to lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your thyroid cancer is less than 4 cm wide
- You have cancer in both sides of your thyroid, or it has spread to neck lymph nodes
- Your vocal cords are working normally (checked a week before surgery)
- You have not had thyroid surgery before, and you need to have your whole thyroid removed
- Your blood pressure is under control, and you are able to talk and understand after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to use a medication called mitoxantrone during robotic thyroid cancer surgery. The goal is to see if it helps protect the parathyroid glands (tiny glands near your thyroid) and improve surgery outcomes.
This study looks at whether certain cancer “targeted therapy” medicines can make radioactive iodine (RAI) therapy work better for thyroid cancer that has spread to the lungs. It also involves taking special whole-body scans to measure how much radioactive iodine gets taken up by the cancer.
This trial tests whether removing central neck lymph nodes during thyroid surgery improves outcomes for patients with 2 to 4 cm papillary thyroid cancer. It focuses on people who have no signs of cancer spread before surgery.
This trial is for people with low-risk papillary thyroid cancer. It compares two surgical approaches: one that removes just the thyroid gland, and another that also removes some lymph nodes in the center of the neck as a preventive measure. The goal is to see if removing these lymph nodes helps prevent the cancer from coming back.
This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.
This trial compares two types of neck surgery for people with papillary thyroid cancer that has spread to a small number of lymph nodes in the neck. The goal is to see if a less extensive lymph node removal works just as well as the standard more extensive surgery.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.